In AD research, disrupting the glycolysis/H4K12la/PKM2 positive feedback loop with PKM2 inhibitors, such as shikonin or compound 3 K, reduced lactate and H4K12la levels, inhibited pro-inflammatory microglial activation, and improved spatial learning and memory in AD mice [92]. This evidence concerns the gene PKM and Alzheimer disease.